Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-29

Clinical Trial Update: Docosahexaenoic Acid on Breath Holding Spells in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating docosahexaenoic acid for breath holding spells in children is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Breath Holding Attack | Phase 3 | Status: RECRUITING